These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15923589)

  • 1. Controversy in folinic acid administration after fluorouracil.
    Yildirim Y; Akcali Z; Ozyilkan O
    J Clin Oncol; 2005 Jun; 23(16):3862; author reply 3862-3. PubMed ID: 15923589
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronotherapy with 5-fluorouracil, oxaliplatin, and folinic acid in colorectal cancer.
    Sandor V
    Lancet; 1997 Nov; 350(9087):1325-6. PubMed ID: 9357429
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ambulatory chemotherapy schedule for metastatic colorectal cancer].
    Watine J; Soulage C
    Presse Med; 2001 Jan; 30(1):35. PubMed ID: 11210587
    [No Abstract]   [Full Text] [Related]  

  • 4. Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?
    Mayer RJ
    J Clin Oncol; 2007 Sep; 25(27):4165-7. PubMed ID: 17709796
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.
    Culy CR; Clemett D; Wiseman LR
    Drugs; 2000 Oct; 60(4):895-924. PubMed ID: 11085200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
    Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Tang LN; Zhang W
    Chin Med J (Engl); 2006 Nov; 119(21):1829-33. PubMed ID: 17097039
    [No Abstract]   [Full Text] [Related]  

  • 7. A Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experience.
    Xu N; Fang WJ; Zhang XC; Yu LF; Bao HY; Shi GM; Huang S; Shen P
    Cancer Invest; 2007; 25(7):599-605. PubMed ID: 17882631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendation for irinotecan, 5-fluorouracil, and leucovorin as first-line therapy for colorectal cancer.
    Fisher MD
    Clin Colorectal Cancer; 2001 Aug; 1(2):82-4. PubMed ID: 12445364
    [No Abstract]   [Full Text] [Related]  

  • 9. [5-fluorouracil and leucovorin therapy for advanced colorectal cancer].
    Shimoyama S; Kondo K; Kataoka M
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():356-9. PubMed ID: 14574912
    [No Abstract]   [Full Text] [Related]  

  • 10. Scheduling of fluorouracil: a forget-me-not in the jungle of doublets.
    Sobrero AF
    J Clin Oncol; 2004 Jan; 22(1):4-6. PubMed ID: 14665617
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution of systemic therapy for metastatic colorectal cancer.
    Geh JI; Ma YT
    Colorectal Dis; 2011 Aug; 13(8):852-4. PubMed ID: 21762349
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progress of chemotherapy in colorectal cancer].
    Komatsu Y
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1771-6. PubMed ID: 18064761
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic chemotherapy for metastatic colorectal cancer: reasons to combine.
    Calvo E
    Clin Colorectal Cancer; 2002 Nov; 2(3):170-2. PubMed ID: 12482333
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxaliplatin for colorectal cancer in the United States: better late than never.
    Chau I; Cunningham D
    J Clin Oncol; 2003 Jun; 21(11):2049-51. PubMed ID: 12775727
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant therapy: new treatment options with oxaliplatin-based chemotherapy.
    Chu E
    Clin Colorectal Cancer; 2005 Jul; 5(2):80-1. PubMed ID: 16098246
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gleaning from the American Oncology Congress. A new standard in colorectal carcinoma].
    MMW Fortschr Med; 2002 Oct; 144(41):61. PubMed ID: 12474374
    [No Abstract]   [Full Text] [Related]  

  • 17. 5-fluorouracil, folinic acid and oxaliplatin administered via hepatic arterial infusion as regional second-line therapy for advanced colorectal cancer.
    Meyer L; Hildebrandt B; Riess H
    Oncology; 2003; 64(4):473-4. PubMed ID: 12759548
    [No Abstract]   [Full Text] [Related]  

  • 18. Turning point for colorectal cancer clinical trials.
    Meropol NJ
    J Clin Oncol; 2006 Jul; 24(21):3322-4. PubMed ID: 16849744
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumori. Chronotherapy Study Group of the European Organization for Research and Treatment of Cancer.
    Garufi C; Dogliotti L; Terzoli E; Focan C; Smaaland R; Chollet P; Perpoint B; Lévi F
    Tumori; 1999; 85(2):149-50. PubMed ID: 10363085
    [No Abstract]   [Full Text] [Related]  

  • 20. Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer.
    Comella P; Massidda B; Palmeri S; Putzu C; De Rosa V; Izzo F; Fiore F; Casaretti R; Sandomenico C
    Anticancer Drugs; 2006 Sep; 17(8):985-92. PubMed ID: 16940809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.